Navigation Links
Medline Signs 3-Year Purchasing Agreement for Mouth Rinse From Chester Labs
Date:6/2/2008

MUNDELEIN, Ill., June 2 /PRNewswire/ -- Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical supplies, announced today that it has signed a three-year agreement to purchase mouth rinse from Chester Labs, a manufacturer of liquid products for personal care, infection control and diagnostic use in medical facilities.

"Given recent shortages of mouth rinse in the healthcare market, we are happy to extend our partnership with Chester Labs to continue providing our customers with mouth rinse that meets FDA standards," said Andy Mills, President of Medline.

This agreement will ensure that Medline receives an increased volume of alcohol-free mouth rinse to accommodate its customer needs. Medline distributes the mouth rinse under the Medline label to hospitals, medical centers and long-term care facilities nationwide.

"Chester Labs is very pleased to enter into this agreement with Medline. It gives Chester the security to invest in this segment of our business to increase capacity at a time when it is very much needed. It also provides Medline and its customers a reliable, high-quality source of supply," said John Armstrong, President of Chester Labs.

Each lot of mouth rinse is tested for microbial contamination of (pathogenic) bacteria such as B. cepacia. All bottles carry a sealed foil cap to protect the integrity of the product.

About Medline

Medline, headquartered in Mundelein, IL, manufactures and distributes more than 100,000 products to hospitals, extended care facilities, surgery centers, home care dealers and agencies and other markets. Total revenue for Medline in 2007 exceeded $2.86 billion. Meeting national and international quality standards, Medline is FDA QSR compliant and ISO 13485 certified. Medline serves on major industry quality committees to develop guidelines and standards for medical product use, including the FDA Midwest Steering Committee, AAMI Sterilization and Packaging Committee, and various ASTM committees. For more information on Medline, visit our Web site, http://www.medline.com.

About Chester Labs

Chester Labs, headquartered in Cincinnati, Ohio, manufactures liquid products for personal care, infection control and diagnostic use in medical facilities. Chester Labs is a 13485:2003 and 9001:2000 certified manufacturing facility.


'/>"/>
SOURCE Medline Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
2. Medline and 3M Agree to Strategic Partnership in Electrosurgery
3. Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests
4. Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine
5. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
6. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
7. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
8. Quintiles Signs Agreement to Acquire Eidetics
9. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
10. Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
11. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017  Champions Oncology, Inc. (NASDAQ: ... and sale of advanced technology solutions and products to ... announced the addition of new cohorts of PDX models ... models will expand Champions, product line in hepatocellular cancer, ... cancer, AML, and non-small cell lung cancer (including EGFR ...
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):